Who's Responsible for Cannabis Safety in France?

France has a reputation as one of Europe's strictest countries on cannabis, and it earns it: recreational use is still a criminal offense. Yet France also has a medical cannabis framework and a large consumer CBD market. Both are kept on a very short leash.

Here is who controls each, and why "legal" in France comes with heavy asterisks.

The short version: France's medical cannabis is a pharmacy medicine, authorized and monitored by the national medicines agency, but it is still stuck in a transitional pilot. The CBD you can buy is legal only if it stays at or under 0.3% THC and makes no health claims.

Medical cannabis: authorized, but barely available

France ran a national medical cannabis experiment from 2021 to the end of 2024, enrolling around 3,000 patients with conditions like severe nerve pain, some epilepsies, and cancer symptoms. A 2024 law then created a permanent five-year authorization for cannabis medicines, judged by the medicines agency on the same quality and safety standards as the trial.

But the rollout has stalled. As of now the implementing rules have not been finalized, no new patients are being admitted, and only a shrinking group from the original trial is still treated. A functioning, generally available medical program is expected to arrive later, not today.

Who checks that it is safe

On the medical side, cannabis is handled as a pharmaceutical:

The national medicines safety agency (ANSM) authorizes each product after reviewing its quality and safety, and monitors it for side effects.

Producers must supply pharmaceutical-grade product with defined THC-to-CBD ratios and batch quality control.

A doctor prescribes it as a last-line option, and only a pharmacy dispenses it.

The CBD you can actually buy

The everyday cannabis product in France is CBD, and it became legal only after Europe's top court ruled in 2020 that CBD is not a narcotic, followed by France's highest administrative court striking down a ban on CBD flower. The rules that keep it in bounds:

A hard THC cap: a legal CBD product must contain no more than 0.3% THC, checked by lab testing. Above that, it is illegal cannabis.

No health claims: CBD is sold as a consumer product, not a medicine, so sellers cannot claim it treats or cures anything. The consumer-protection and anti-fraud authority enforces this with seizures and recalls.

Labelling: French-language labels must show the cannabinoid content, the batch, and the maker.

One recent twist worth knowing: in May 2026 France pulled ingestible CBD foods (gummies, edible oils, teas, capsules) from sale, treating them as unauthorized novel foods, while still allowing CBD flower, vape liquids, and cosmetics. That enforcement is recent and contested, so expect it to keep moving.

The twist: strict by default

France is close to the opposite of a US recreational state. Recreational use stays a crime, the medical channel is a pharmacy-only program still stuck in transition, and the consumer market is capped at a trace amount of THC with no health claims allowed. Safety here is enforced less by lab certificates on a shop shelf and more by keeping intoxicating cannabis out of the legal market almost entirely.

What it means for you

If you buy CBD in France, the safety line is simple: is it at or under 0.3% THC, honestly labelled, and sold without medical promises? For medical cannabis, real access is still limited to a small transitional group. Anything stronger, sold as recreational, is outside the law and outside any safety testing.

Curious how this works where cannabis is sold recreationally? See our state-by-state walkthrough of who signs off on a US cannabis lab report at weed-central.com/learn/coa (https://weed-central.com/learn/coa?utm_source=newsletter.weed-central.com&utm_medium=newsletter&utm_campaign=who-s-responsible-for-cannabis-safety-in-france).

This article is general information, not legal or medical advice. Cannabis and CBD rules in France are evolving; verify the current requirements before relying on any detail.